Table I.
Sample distribution.
| OSAS | |||||
|---|---|---|---|---|---|
| Mild | Moderate | Severe | Total | ||
| Sex | Female | 85 | 94 | 145 | 324 |
| Male | 262 | 269 | 330 | 861 | |
| Total | 347 | 363 | 475 | 1185 | |
| Hypertension | Female | 46 (54.12%) | 76 (80.85%) | 79 (54.48%) | 201 |
| Male | 81 (30.92%) | 81 (30.11%) | 165 (50.00%) | 327 | |
| Total | 127 | 157 | 244 | 528 | |
| Diabetes Mellitus | Female | 32 (38.65%) | 30 (31.91%) | 36 (24.83%) | 98 |
| Male | 16 (6.11%) | 33 (12.27%) | 102 (30.91%) | 151 | |
| Total | 48 | 63 | 138 | 249 | |
| Dyslipidaemia | Female | 0 (0.00%) | 38 (40.43%) | 43 (22.66%) | 81 |
| Male | 11 (4.20%) | 34 (12.64%) | 4 (1.21%) | 49 | |
| Total | 11 | 72 | 47 | 130 | |
| Metabolic Syndrome | Female | 28 (32.94%) | 30 (31.91%) | 23 (15.86%) | 81 |
| Male | 4 (1.53%) | 17 (6.32%) | 67 (20.30%) | 88 | |
| Total | 32 | 47 | 90 | 169 | |
Sample distribution of patients stratified by gender and degree of OSAS in relation to hypertension, diabetes mellitus, dyslipidaemia and metabolic syndrome.